May 21, 2007 - Patient Comfort Systems Inc. recently announced its new product line of medical imaging table pads and positioners featuring infection-resistant design with permanent antimicrobial agents, created in part to address the growing threat of infections spread by contact, which includes aggressive antibiotic-resistant bacteria, or “super bugs,” such as MRSA (Methicillin-Resistant Staphylococcus Aureus).

May 21, 2007 — A new study released by the American Thoracic Society found that medical residents working within the mandated maximum of 80 hours per week experience severe sleepiness, a finding that may have implications for both patient care and resident safety.

May 21, 2007 — Reuters news service reports that a group of Chinese of scientists has developed a glucose meter that allows patients to check their sugar levels without using a finger stick.

The device, which is not named, checks glucose levels by using a weak form of infrared to penetrate the skin on the finger and monitor the blood stream. After undergoing five clinical trials, the device is said to give results with 85 percent accuracy, according to Reuters.

May 21, 2007 — Newswise reports that Vanderbilt study of intensive care unit patients who are breathing with the help of a mechanical ventilator found that a two-step sedation and ventilator weaning protocol — called a “wake up and breathe” strategy — helps patients come off the ventilator faster so that they can be discharged from the ICU and hospital more quickly.

The study was presented at the American Thoracic Society 2007 International Conference in San Francisco.

May 21 — OrbusNeich announced today it has received CE Mark approval for three interventional cardiology products: the Blazer cobalt chromium stent, the Sapphire PTCA dilatation catheter and the Lumina 6F guiding catheter.

Featuring unique dual helix design and thin cobalt chromium stent struts, Blazer enables physicians to overcome the flexibility challenges associated with the slotted tube construction of most stents. In addition, Blazer provides unsurpassed sidebranchability of up to 4.5 mm for effective bifurcation stenting and for maintaining the patency of side branches.

May 21, 2007 - VirtualScopics, Inc., a developer of image-based biomarker solutions, announced today that it released its next generation 2.0 software platform for the use of imaging in clinical trials, delivering operational efficiencies and enhanced reporting in order to expedite customers' clinical trial process.

May 21, 2007 - Canon U.S.A, Inc. announced that it has completed the latest digital radiography (DR) system implementation, which took place at at Riverside Medical Clinic in Southern California, the implementation is its 1,500th DR system installation, marking a milestone for the company.

With eight generations of flat panel sensors, Canon Medical Systems has installed more than 1,500 DR sensor panels throughout Canada, the United States and Latin America, part of the more than 4,500 DR systems that have been installed worldwide by the Canon family of companies.

By CHARLES FORELLE
May 21, 2007 - Hologic Inc. has agreed to buy Cytyc Corp. for $6.2 billion in cash and stock, in a deal that combines two major players in women's health care.

Executives of both companies say the tie-up will increase the opportunity for sales representatives to win over obstetricians and gynecologists, who are critical to recommending that patients use the companies' products.

May 21, 2007 – SourceMedical recently announced new contract signings for the company's SourceRad solution with Nueterra Healthcare LLC, a provider of development and management services to surgical facilities and Regent Surgical Health, a developer and manager of surgery centers and physician-owned hospitals around the country.

May 18, 2007 — Acambis plc (Acambis), a biotechnology company targeting infectious diseases with novel vaccines, announces that the Vaccines and Related Biological Products Advisory Committee of the FDA voted unanimously that Acambis' smallpox vaccine, ACAM2000, is both safe and efficacious.

Subscribe Now